» Authors » John E Pimanda

John E Pimanda

Explore the profile of John E Pimanda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 90
Citations 3631
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Putri G, Anders S, Pyl P, Pimanda J, Zanini F
Bioinformatics . 2022 May; 38(10):2943-2945. PMID: 35561197
Summary: HTSeq 2.0 provides a more extensive application programming interface including a new representation for sparse genomic data, enhancements for htseq-count to suit single-cell omics, a new script for data...
12.
Thoms J, Pimanda J, Heidenreich O
Blood . 2021 Oct; 138(15):1289-1291. PMID: 34647985
No abstract available.
13.
Yang J, Gao C, Liu M, Liu Y, Kwon J, Qi J, et al.
Cancer Res . 2021 Oct; 81(23):6018-6028. PMID: 34593523
Oncofetal protein SALL4 is critical for cancer cell survival. Targeting SALL4, however, is only applicable in a fraction of cancer patients who are positive for this gene. To overcome this...
14.
Thoms J, Truong P, Subramanian S, Knezevic K, Harvey G, Huang Y, et al.
Blood . 2021 Jun; 138(16):1441-1455. PMID: 34075404
Changes in gene regulation and expression govern orderly transitions from hematopoietic stem cells to terminally differentiated blood cell types. These transitions are disrupted during leukemic transformation, but knowledge of the...
15.
Yeola A, Subramanian S, Oliver R, Lucas C, Thoms J, Yan F, et al.
Sci Adv . 2021 Feb; 7(3). PMID: 33523875
Terminally differentiated murine osteocytes and adipocytes can be reprogrammed using platelet-derived growth factor-AB and 5-azacytidine into multipotent stem cells with stromal cell characteristics. We have now optimized culture conditions to...
16.
Tavassoli H, Rorimpandey P, Kang Y, Carnell M, Brownlee C, Pimanda J, et al.
Small . 2020 Dec; 17(8):e2006176. PMID: 33369875
To advance the understanding of cardiomyocyte (CM) identity and function, appropriate tools to isolate pure primary CMs are needed. A label-free method to purify viable CMs from mouse neonatal hearts...
17.
Jolly C, Pimanda J
Blood . 2020 Aug; 136(7):777-779. PMID: 32790853
No abstract available.
18.
Carmichael C, Wang J, Nguyen T, Kolawole O, Benyoucef A, De Maziere C, et al.
Blood . 2020 May; 136(8):957-973. PMID: 32369597
Modulators of epithelial-to-mesenchymal transition (EMT) have recently emerged as novel players in the field of leukemia biology. The mechanisms by which EMT modulators contribute to leukemia pathogenesis, however, remain to...
19.
Anande G, Deshpande N, Mareschal S, Batcha A, Hampton H, Herold T, et al.
Clin Cancer Res . 2020 Mar; 26(14):3597-3607. PMID: 32122925
Purpose: RNA splicing is a fundamental biological process that generates protein diversity from a finite set of genes. Recurrent somatic mutations of splicing factor genes are common in some hematologic...
20.
Khanna A, Thoms J, Stringer B, Chung S, Ensbey K, Jue T, et al.
Mol Cancer Res . 2020 Feb; 18(5):709-722. PMID: 32079743
High-constitutive activity of the DNA damage response protein checkpoint kinase 1 (CHK1) has been shown in glioblastoma (GBM) cell lines and in tissue sections. However, whether constitutive activation and overexpression...